Why the study?
Do therapeutic interventions proven in the general population reduce cardiovascular morbidity and mortality in patients with end-stage renal disease?
Do therapeutic interventions proven in the general population reduce cardiovascular morbidity and mortality in patients with end-stage renal disease?
Answers are grounded in this paper and cite their sources.
This review highlights the consistent failure of traditional cardiovascular risk reduction strategies (like statins and intensive dialysis) to improve survival in ESRD patients, emphasizing the need for disease-specific trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Covic et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: